{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T13:28:08Z","timestamp":1663248488219},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T00:00:00Z","timestamp":1435276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl."],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00103-015-2191-9","type":"journal-article","created":{"date-parts":[[2015,6,25]],"date-time":"2015-06-25T12:54:45Z","timestamp":1435236885000},"page":"866-874","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Die deutsche Laborlandschaft zu Diagnostik und Antibiotikaresistenztestung bei Neisseria gonorrhoeae"],"prefix":"10.1007","volume":"58","author":[{"given":"Anna","family":"Loenenbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Dudareva-Vizule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Buder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sailer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.K.","family":"Kohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,26]]},"reference":[{"issue":"40","key":"2191_CR1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0968-8080(12)40653-X","volume":"20","author":"F Ndowa","year":"2012","unstructured":"Ndowa F, Lusti-Narasimhan M (2012) The threat of untreatable gonorrhoea: implications and consequences for reproductive and sexual morbidity. Reprod Health Matters 20(40):76\u201382","journal-title":"Reprod Health Matters"},{"key":"2191_CR2","unstructured":"European Centre of Disease Prevention and Control (ECDC) (2012) Sexually transmitted infections in Europe, 1990\u20132010. http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/201206-Sexually-Transmitted-Infections-Europe-2010.pdf . Zugegriffen: 2. Sept. 2014"},{"key":"2191_CR3","doi-asserted-by":"crossref","unstructured":"Unemo M, European STIGEB (2012) The 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults recommends dual antimicrobial therapy. Euro Surveill 17(47)","DOI":"10.2807\/ese.17.47.20323-en"},{"key":"2191_CR4","unstructured":"Word Health Organization (WHO) (2012) Global incidence and prevalence of selected curable sexually transmitted infections: 2008"},{"key":"2191_CR5","unstructured":"Centers for Disease Control and Prevention (CDC) (2013) Antibiotic resistance threats in the United States. http:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/ . Zugegriffen: 1. Dez. 2014"},{"key":"2191_CR6","unstructured":"Word Health Organization (WHO) (2011) Emergence of multi-drug resistant Neisseria gonorrhoeae \u2013 Threat of global rise in untreatable sexually transmitted infections. Factsheet. http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/who_rhr_11_14\/en\/ . Zugegriffen: 3. May. 2013"},{"key":"2191_CR7","unstructured":"Landesuntersuchungsanstalt Sachsen (2012) LUA-Mitteilungen 04\/2012: Landesuntersuchungsanstalt f\u00fcr das Gesundheits- und Veterin\u00e4rwesen Sachsen. https:\/\/publikationen.sachsen.de\/bdb\/artikel\/17131 . Zugegriffen: 27. Feb. 2014"},{"key":"2191_CR8","unstructured":"Landesuntersuchungsanstalt Sachsen (2014) LUA-Mitteilungen 01\/2014: Landesuntersuchungsanstalt f\u00fcr das Gesundheits- und Veterin\u00e4rwesen Sachsen. https:\/\/publikationen.sachsen.de\/bdb\/artikel\/21733 . Zugegriffen: 30. May. 2014"},{"issue":"2","key":"2191_CR9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/jac\/dku396","volume":"70","author":"SA Buono","year":"2014","unstructured":"Buono SA, Watson TD, Borenstein LA, Klausner JD, Pandori MW, Godwin HA (2014) Stemming the tide of drug-resistant Neisseria gonorrhoeae: the need for an individualized approach to treatment. J Antimicrob Chemother 70(2):374\u2013781","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"2191_CR10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1179\/2047772414Z.000000000216","volume":"108","author":"M Unemo","year":"2014","unstructured":"Unemo M (2014) Challenges with antimicrobial susceptibility testing for Neisseria gonorrhoeae in the era of extensively drug-resistant gonorrhoea \u2013 molecular antimicrobial resistance testing crucial. Pathog Glob Health 108(5):214\u2013215","journal-title":"Pathog Glob Health"},{"key":"2191_CR11","unstructured":"Word Health Organization (WHO) (2014) Antimicrobial resistance: global report on surveillance 2014. http:\/\/www.who.int\/drugresistance\/documents\/surveillancereport\/en\/ . Zugegriffen: 23. Juli. 2014"},{"key":"2191_CR12","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2012) Response plan to control and manage the threat of multidrug-resistant gonorrhoea in Europe. http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/1206-ECDC-MDR-gonorrhoea-response-plan.pdf . Zugegriffen: 18. Okt. 2013"},{"issue":"3","key":"2191_CR13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","volume":"27","author":"M Unemo","year":"2014","unstructured":"Unemo M, Shafer WM (2014) Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev 27(3):587\u2013613","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"2191_CR14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0956462412472837","volume":"24","author":"C Bignell","year":"2012","unstructured":"Bignell C, Unemo M, obotESGEB (2012) European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS 24(2):85\u201392","journal-title":"Int J STD AIDS"},{"key":"2191_CR15","unstructured":"Deutsche STI-Gesellschaft e.\u00a0V. (DSTIG) (2013) Leitlinie \u2013 Gonorrhoe bei Erwachsenen und Adoleszenten. http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/059\u2013004l_S25_Gonorrhoe_bei_Erwachsenen_Adoleszenten_2014\u201301_01.pdf . Zugegriffen: 10. Nov. 2014"},{"issue":"4","key":"2191_CR16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.eimc.2011.11.010","volume":"30","author":"D Carnicer-Pont","year":"2012","unstructured":"Carnicer-Pont D, Smithson A, Fina-Homar E, Bastida MT , Gonococcus antimicrobial resistance surveillance working G (2012). First cases of neisseria gonorrhoeae resistant to ceftriaxone in Catalonia, Spain, May 2011. Enferm Infecc Microbiol Clin 30(4):218\u2013219","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"6","key":"2191_CR17","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/jac\/dkt034","volume":"68","author":"DA Lewis","year":"2013","unstructured":"Lewis DA, Sriruttan C, Muller EE, Golparian D, Gumede L, Fick D et al (2013) Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. J Antimicrob Chemother 68(6):1267\u20131270","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"2191_CR18","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","volume":"56","author":"M Unemo","year":"2012","unstructured":"Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P (2012) High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 56(3):1273\u20131280","journal-title":"Antimicrob Agents Chemother"},{"key":"2191_CR19","doi-asserted-by":"crossref","unstructured":"Unemo M, Golparian D, Stary A, Eigentler A (2011) First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill 16(43)","DOI":"10.2807\/ese.16.43.19998-en"},{"key":"2191_CR20","doi-asserted-by":"crossref","first-page":"E","DOI":"10.1111\/j.1749-6632.2011.06215.x","volume":"1230","author":"M Unemo","year":"2011","unstructured":"Unemo M, Shafer WM (2011) Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future. Ann N Y Acad Sci 1230:E19\u2013E28","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"2191_CR21","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1586\/eri.09.63","volume":"7","author":"JW Tapsall","year":"2009","unstructured":"Tapsall JW, Ndowa F, Lewis DA, Unemo M (2009) Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther 7(7):821\u2013834","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2191_CR22","volume-title":"Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae","author":"Word Health Organization (WHO)","year":"2012","unstructured":"Word Health Organization (WHO) (2012) Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. WHO, Geneva. http:\/\/whqlibdoc.who.int\/publications\/2012\/9789241503501_eng.pdf"},{"issue":"7","key":"2191_CR23","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","volume":"55","author":"M Ohnishi","year":"2011","unstructured":"Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K et al (2011) Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 55(7):3538\u20133545","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2191_CR24","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1071\/SH13077","volume":"10","author":"PJ Read","year":"2013","unstructured":"Read PJ, Limnios EA, McNulty A, Whiley D, Lahra MM (2013) One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500\u00a0mg ceftriaxone in Sydney, Australia. Sex Health 10(5):460\u2013462","journal-title":"Sex Health"},{"key":"2191_CR25","doi-asserted-by":"crossref","unstructured":"Unemo M, Golparian D, Potocnik M, Jeverica S (2012) Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Euro Surveill 17(25)","DOI":"10.2807\/ese.17.25.20200-en"},{"key":"2191_CR26","doi-asserted-by":"crossref","unstructured":"Unemo M, Golparian D, Hestner A (2011) Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill 16(6)","DOI":"10.2807\/ese.16.06.19792-en"},{"key":"2191_CR27","doi-asserted-by":"crossref","unstructured":"Chen SC, Yin YP, Dai XQ, Unemo M, Chen XS (2014) Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing, China. J Antimicrob Chemother 55(7):3538\u20133545","DOI":"10.1093\/jac\/dku245"},{"key":"2191_CR28","doi-asserted-by":"crossref","unstructured":"Ison CA, Alexander S (2011) Antimicrobial resistance in Neisseria gonorrhoeae in the UK: surveillance and management. Expert Rev Anti Infect Ther 9(10):867\u2013876","DOI":"10.1586\/eri.11.103"},{"issue":"5\u20136","key":"2191_CR29","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ijmm.2014.04.001","volume":"304","author":"NN Horn","year":"2014","unstructured":"Horn NN, Kresken M, Korber-Irrgang B, Gottig S, Wichelhaus C, Wichelhaus TA et al (2014) Antimicrobial susceptibility and molecular epidemiology of Neisseria gonorrhoeae in Germany. Int J Med Microbiol 304(5\u20136):586\u2013591","journal-title":"Int J Med Microbiol"},{"issue":"5","key":"2191_CR30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s10096-006-0134-y","volume":"25","author":"M Enders","year":"2006","unstructured":"Enders M, Turnwald-Maschler A, Regnath T (2006) Antimicrobial resistance of Neisseria gonorrhoeae isolates from the Stuttgart and Heidelberg areas of southern Germany. Eur J Clin Microbiol Infect Dis 25(5):318\u2013322","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2191_CR31","doi-asserted-by":"crossref","unstructured":"Wagner J, Tebbe B, H\u00f6rnle R, Chahin M, Arvand M, Wendt C et al (2000) Antibiotikaempfindlichkeit von Neisseria-gonorrhoeae-Isolaten in Berlin. Hautarzt 51(9):666\u2013669","DOI":"10.1007\/s001050051192"},{"key":"2191_CR32","unstructured":"Ungeheuer J, Michalewski-Zietz I (2001) Stark zunehmende Resistenz von Neisseria gonorrhoeae gegen Ciprofloxacin in Norddeutschland. Chemotherapie-J 10(1):35"},{"issue":"10","key":"2191_CR33","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/BF01691501","volume":"14","author":"V Schafer","year":"1995","unstructured":"Schafer V, Enzensberger R, Schneider C, Rickmann J, Nitschke-Ozbay H, Brade V (1995) Epidemiology of penicillin-resistant Neisseria gonorrhoeae in Frankfurt, Germany. Eur J Clin Microbiol Infect Dis 14(10):914\u2013918","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2191_CR34","unstructured":"Robert Koch-Institute (RKI) (2014) Webpage ARS \u2013 Antibiotika-Resistenz-Surveillance in Deutschland. http:\/\/ars.rki.de\/ . Zugegriffen: 2. Sept. 2014"},{"key":"2191_CR35","unstructured":"Konsiliarlabor f\u00fcr Gonokokken (2014) Fachinformationen \u2013 Resistenz Gonorrhoe 2013. http:\/\/www.vivantes.de\/fuer-sie-vor-ort\/details\/einrichtung\/vivantes-klinikum-neukoelln\/klinik\/dermatologie-und-venerologie\/seite\/fachinformationen\/action\/custompage\/ . Zugegriffen: 2. Sept. 2014"},{"key":"2191_CR36","unstructured":"Konsililarlabor f\u00fcr Gonokokken (2014) Webpage Konsililarlabor f\u00fcr Gonokokken, Vivantes-Klinikum, Berlin, Germany. Projekte EURO GASP und GORENET: Konsililarlabor f\u00fcr Gonokokken. http:\/\/www.vivantes.de\/fuer-sie-vor-ort\/details\/einrichtung\/vivantes-klinikum-neukoelln\/klinik\/dermatologie-und-venerologie\/seite\/projekte-euro-gasp-gorenet\/action\/custompage\/ . Zugegriffen: 25. Sept. 2014"},{"key":"2191_CR37","doi-asserted-by":"crossref","unstructured":"Unemo M, Shipitsyna E, Domeika M, Eastern European Sexual and Reproductive Health Network Antimicrobial Resistance Group (2011) Gonorrhoea surveillance, laboratory diagnosis and antimicrobial susceptibility testing of Neisseria gonorrhoeae in 11 countries of the eastern part of the WHO European region. APMIS 119(9):643\u2013649","DOI":"10.1111\/j.1600-0463.2011.02780.x"},{"issue":"3","key":"2191_CR38","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/jac\/dkl264","volume":"58","author":"CA Ison","year":"2006","unstructured":"Ison CA, Martin IM, Lowndes CM, Fenton KA, ESSTI Network (2006) Comparability of laboratory diagnosis and antimicrobial susceptibility testing of Neisseria gonorrhoeae from reference laboratories in Western Europe. J Antimicrobial Chemother 58(3):580\u2013586","journal-title":"J Antimicrobial Chemother"},{"key":"2191_CR39","unstructured":"Robert Koch-Institut (RKI) (2014) Webpage GORENET (Gonokokken-Resistenz-Netzwerk). http:\/\/www.rki.de\/DE\/Content\/InfAZ\/G\/Gonorrhoe\/GORENET.html . 29. Sept. 2014"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-015-2191-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00103-015-2191-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-015-2191-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-015-2191-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T09:49:24Z","timestamp":1652608164000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00103-015-2191-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,26]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["2191"],"URL":"https:\/\/doi.org\/10.1007\/s00103-015-2191-9","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,26]]}}}